Drug intelligence / Profile preview

Shin-yi-san

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Shin-yi-san is a classic Traditional Chinese Medicine (TCM) herbal formula primarily utilized for the treatment of nasal and respiratory conditions, most notably allergic rhinitis, sinusitis, and nasal congestion. The formula's primary active component is derived from *Magnolia biondii* (Xinyi), which is typically combined with other medicinal herbs such as *Angelica dahurica*, *Mentha haplocalyx*, and *Glycyrrhiza uralensis*. Its therapeutic profile is characterized by multi-target immunomodulatory and anti-inflammatory activities. Research indicates that Shin-yi-san reduces serum IgE levels, suppresses the production of Th2-associated cytokines like Interleukin-5 (IL-5) and Th1 cytokines like Interferon gamma (IFN-gamma), while simultaneously enhancing the production of the anti-inflammatory cytokine Interleukin-10 (IL-10). It also demonstrates the ability to suppress cyclooxygenase-2 (COX-2) mRNA expression in neutrophils. In clinical practice, particularly in Taiwan, it is frequently co-prescribed with other formulas such as Xiao-qing-long-tang to manage perennial allergic rhinitis.

Other names
Xinyi SanXin-Yi-SanMagnolia Flower PowderXinyi Powder
02

Targets

CYP1A2 (Cytochrome P450 1A2)IL10 (Interleukin-10)IL-5 (Interleukin 5)IFNG (Interferon gamma)

Beyond the preview

Go deeper on Shin-yi-san.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shin-yi-san.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call